BNM-III-170
| Code | Size | Price |
|---|
| TAR-T39300-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
BNM-III-170 is able to inhibit HIV-1 viral entry into target cells.
CAS:
1859189-55-1
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Fritschi CJ, et al. Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics. ACS Med Chem Lett. 2021 Oct 29;12(11):1824-1831.